Effective estimation of second cancer risks and resultant possible improvements of treatment protocols
Effective estimation of second cancer risks and resultant possible improvements of treatment protocols
有效评估第二种癌症风险并由此可能改进治疗方案
批准号：
222886
负责人：
Sivaloganathan Sivabal
金额：
$17.08万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-10-01 至 2013-10-01
关键词：
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It is estimated that 3.5% of the population are cancer survivors, a prevalence that has tripled in North America since 1971. For many patients cured of their initial cancer, their treatment can give rise to significant delayed morbidity, and those origina
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
